The goal of the presented study was to compare the proliferation of different U118 MG and U251 MG glioblastoma cell lines irradiated with proton beam or X-rays in dose range 0.5-10.0 Gy. Cytokinesis-block micronucleus (CBMN) assay was carried out to study changes in proliferation presented as nuclear division index (NDI).
Introduction
Glioblastoma multiforme (GBM) is one of the most common and aggressive types of primary brain tumors with an expected survival of usually less than 2 years [1] . GBM is difficult to treat cancer because it contains heterogenous proliferating and radioresistant cells. Furthermore, these cells may penetrate neighboring tissues [2] . Current treatments include surgery, systemic temozolomide (TMZ) chemotherapy and radiotherapy [3] . For radiotherapy, there are a number of new prospects such as proton therapy which offers compared to photons better dose delivery and distribution, that can be exploited to reduce the probability of collateral normal tissue damage and post-treatment complication [4] . Radiation damage to DNA is believed to be a critical mechanism giving rise to cell death (apoptosis or necrosis) after exposure and predicting the response to treatment [5] .
Recent studies reported that disturbance of the DNA damage checkpoint and enhanced DNA repair capacity in gliomas may lead to radioresistance [6] . The different cell cycle time, genomic instability, the efficacy of DNA repair processes or p53 (tumor suppressor) methylation status may also influence the effects of therapy [7] . Proliferation rate and intrinsic cellular radiosensitivity of tumor tissue are potential predictors of radiation response and may assist the choice of the best treatment for the individual patient [8] . Therefore, predictive assays of tumor growth for individual treatment of patients with cancer recurrence are required.
Understanding of the cellular response and discovering the underlying mechanism is critical for optimization of the proton radiotherapy treatment scheme and may help to identify patients who will benefit from radiotherapy [9] .
The goal of our study was to compare the impact of therapeutic proton beam irradiation (70 MeV) with the photon therapy (X-rays, 250 kV) in dose range from 0.5 Gy to 10 Gy on the proliferation of two glioblastoma multiforme U118 MG and U251 MG human cell lines (both classified as WHO grade IV). Studies were designed to compare morphology and confluency of GBM cells after different doses of proton beam irradiation vs. X-rays and analyze the dose-response effect between the nuclear division index (NDI) values and studied types of radiation.
Experimental details

Cell cultures
The human glioblastoma cell lines (U118 MG, U251 MG) were used as an in vitro model. The U118 MG was obtained from the ATCC ® ( 
Cytokinesis-block micronucleus assay and data processing
Cytokinesis-block micronucleus (CBMN) assay was carried out to study index and changes of proliferation presented as nuclear division index (NDI). CBMN assay was performed according to the method described by Fenech M. [10] . Immediately after irradiation, the cells were treated with 3 µM cytochalasin B (Merck) dissolved in dimethylsulfoxide. After 72 hours of incubation, the cells were fixed in methanol: N represents the total number of cells analyzed.
Statistical analysis
The data analysis was performed using the Microsoft Office Excel 2018. NDI and dose-response curves were fitted in the OriginPro 2018b 64 bit (OriginLab Co.
Northampton. MA. USA). For all data sets the 3-sigma limit test was used to determine whether the distribution of values was statistically relevant (p<0.05).
Results and discussion
Our objective here was to determine the differences in the response of two different glioblastoma cell lines and the individual difference in dose-range of proton therapy vs. photon therapy of each cell line. The literature data showed that the response of GBM to X-rays compared to proton therapy may be not satisfactory especially for tumors located near to critical organs at risk [13] . The growth potential for various GBMs results in re-growth of tumor after a specific time for a given patient, according to a rule that the higher proliferation rate, the shorter turnover time [14] .
Genetic background of each glioblastoma cell line also influences the response of cells to radiation exposure [15] . Recent studies showed that apart from the genetic background, the altered elasticity, shape, cytological structure and adhesiveness of tumor cells may have an impact in tumor invasiveness and therefore a response to therapies [16] . In our studies, morphologically the studied cell types look different.
For illustration series of photos at two different magnification (4.000 and 10.000 x) for both cell lines irradiated by protons or X-rays in the whole dose range were presented in Fig. 2 . The protrusions in U251 MG cells were shorter and more branched than in U118 MG cells (Fig. 2) . Nevertheless, for all doses, types of used radiation and both cell lines, the proliferation status was measured.
NDI values as a function of X-rays and protons for U118 MG and U251 MG
were presented in Fig. 3 A-B , respectively. In our study for controls (non-irradiated cells), we observed statistically significant differences in mean values of proliferation index between U118 MG (1.19 +/-0.21) and U251 MG (1.78 +/-0.25). As accepted in radiobiological studies, to evaluate the dose-response effect, for both types of radiation, the linear-quadratic fitting was implemented by the least square method and the goodness of the fit was calculated using Chi-squared test [11, 12] . The fitting coefficients obtained for NDI distribution for U118 MG and U251 MG cell lines are presented in Table 1 . The R-Square values calculated for U251 MG achieved 0.69 for X-rays and 0.90 for protons showing the dose-dependent relationship (Fig. 3B ). A different case is observed when it comes to R-Square values for U118 MG cell line, where non-dependence dose relationship was observed (0.07 for X-rays, 0.39 post proton radiation). We also did not find statistically significant differences between NDI values for the same doses of protons and X-rays for U118 MG in the whole doserange. The distribution of NDI values achieved constant-like-shaped from 0.0 Gy to 10 Gy (Fig. 3A) indicating that both radiation types appear to have a similar effect on the U118 MG cell line without dosage effect. Although, the U251 MG results show different radiation influence on the NDI values, only points 4.0 Gy and 8.0 Gy were statistically relevant (p<0.05, Fig. 3B ). For this type of GBM cells proton therapy inhibit strongly NDI, mostly in the dose range of 2-8.0 Gy. As a contrast in the whole study, the highest NDI values among studied cells and types of radiation were observed for U 251 MG cells treated by X-rays. Surprisingly, the highest NDI was achieved for U 251 MG after 4 Gy of X-rays. In order to examine if the obtained results for this point are correct, a blind test of repeated analysis with no opportunity to consult the results was performed. The measuring value was in agreement with previously achieved for this dose.
Obtained results indicated that photon therapy may stimulate cells to faster growing to achieve higher values than control, that is in agreement with observations of other researchers. L. Ye et al. showed that Bmi-1 (B-lymphoma Mo-MLV insertion region 1) from the U87 MG cell line having the same grade as U118 MG has been proposed as an oncogene that suppresses the aging of cancer cells and thus induces radioresistance. A dose of at least 6 Gy of X-rays resulted in an increase of Bmi-1 in U87 MG cell line [17] . Therefore, Bmi-1 might be important for cell radioresistance and might slightly change the NDI values of U118 MG cell line in comparison to U251 MG. It should be noted that U118 MG and U251 MG has been classified as the same grade IV being the most malignant but were isolated from different donors [18, 19] .
Actually, radiation is considered as a part of the care standard for the treatment of GBM, but individualized risk predictions and treatment decisions are made mainly of classified grade [20] . Our studies on glioblastoma multiforme proliferation index may have an impact on personalized treatment planning. The information from screening changes in the tumor cells genome could guide clinical decisions making suggestions that not only classified grade but also the origin of tumor cells and genetic background may influence treatment outcome.
Numerous in vitro radiobiological studies for various cells using protons and photons have been carried out resulting in controversial data [21] . Authors showed that results are strongly influenced by the type of cells, culture condition, dose, dose rate, fractionation and other physical features (i.e. LET, RBE) [22] . S.A. Amundson et al. published that proton irradiation compared to X or gamma irradiation increases gene expression level in both their number and strength of response [23] . In the case of rat C6 glioblastoma, similar to human glioblastomas grade IV, the significant decrease in proliferation was found at a dose of 5 Gy and 10 Gy of X-rays after 48 hours of culture [24] . In human glioma MO54, 2 Gy of X-rays stimulated the expression of GAP-43 (growth associated protein 43). GAP-43 is known to be a crucial component of an effective regenerative response in the nervous system [25] . It is also postulated that Xrays can cause an increase in the production of CTSL (lysosomal cysteine protease cathepsin L), as well as increased migration and invasiveness of human glioma cells U251 MG [26] . In the human LN18 glioblastoma cell line, a dose below 2 Gy of Xrays had no effect on proliferation or apoptosis [27] . In our study, the effectiveness of proliferation inhibition by protons was more effective in comparison to X-rays, but only for U251 MG. Proton beam therapy mainly induces ROS-dependent mechanism of DNA damage and consequently brings to apoptosis of GSCs (glioma stem cells) in GBM patients. Thus, proton therapy may give better results than conventional photon therapy in growing inhibition of GBM [28] .
While these data are preliminary our laboratory is further exploring the influence of proton beam and X-rays as a reference on GBM cells response. Moreover, whole genes expression profile analysis of affected GBM cell lines is planned.
Knowledge of genetic differences among GBM cell lines and studying their radiosensitivity may enable to find genetic factors and other regulatory factors such as methylation status responsible for the radioresistance. Consequently, it can help to predict the radiosensitivity of tumors and thus develop appropriate treatment scheme to proton vs. photon therapy.
Conclusions
The main aim of the paper was to examine the influence of proton therapy and X-rays on the proliferation status of GBM human cell lines. The presented preliminary study shows that both types of radiation inhibit the proliferation, but to a different extent depending on the cell line used. A future experimental investigation involving measuring of micronuclei by CBMN assay, gene expression studies and combined radiotherapy with TMZ chemotherapy will enable to better understand the molecular mechanisms of GBM response to applied therapies. Sciences in Krakow using equipment purchased under the project co-financed by the 
